Silk Road Medical, Inc (SILK)
27.49
0.00 (0.00%)
Inactive · Last trade price on Sep 17, 2024
Silk Road Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 17, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 1,117 | 478 | 2,015 | 1,487 | 2,139 | 1,246 | |
Market Cap Growth | - | -76.28% | 35.50% | -30.48% | 71.60% | - |
Enterprise Value | 1,029 | 370 | 1,992 | 1,420 | 2,034 | 1,184 |
Last Close Price | 27.49 | 12.27 | 52.85 | 42.61 | 62.98 | 40.38 |
Price Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 17, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PE Ratio | - | -8.54 | -34.37 | -29.63 | -43.83 | -17.69 |
PS Ratio | 5.63 | 2.70 | 14.53 | 14.65 | 28.43 | 19.67 |
PB Ratio | 7.22 | 3.16 | 12.29 | 18.76 | 19.90 | 17.34 |
P/FCF Ratio | - | -14.26 | -53.60 | -34.03 | -49.84 | -41.35 |
P/OCF Ratio | - | -14.93 | -61.84 | -38.19 | -50.84 | -42.09 |
EV Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 17, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
EV/Sales Ratio | 5.38 | 2.09 | 14.37 | 14.00 | 27.04 | 18.68 |
EV/EBITDA Ratio | - | -6.53 | -39.94 | -30.59 | -48.35 | -43.27 |
EV/EBIT Ratio | - | -6.24 | -38.31 | -29.92 | -47.46 | -42.17 |
EV/FCF Ratio | - | -11.03 | -53.00 | -32.51 | -47.40 | -39.26 |
Financial Efficiency
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 17, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Debt / Equity Ratio | 0.55 | 0.56 | 0.50 | 0.70 | 0.49 | 0.69 |
Debt / FCF Ratio | -2.34 | -2.52 | -2.19 | -1.28 | -1.22 | -1.64 |
Asset Turnover | 0.72 | 0.66 | 0.65 | 0.60 | 0.48 | 0.70 |
Inventory Turnover | 2.02 | 2.04 | 2.04 | 1.83 | 2.10 | 1.98 |
Quick Ratio | 6.28 | 6.77 | 9.46 | 4.68 | 8.01 | 5.86 |
Current Ratio | 7.63 | 7.95 | 10.41 | 5.49 | 8.86 | 6.64 |
Return on Equity (ROE) | -36.45% | -35.39% | -45.25% | -53.35% | -52.81% | -178.70% |
Return on Assets (ROA) | -14.11% | -13.85% | -15.25% | -17.66% | -16.92% | -19.47% |
Return on Invested Capital (ROIC) | -15.69% | -15.37% | -17.05% | -20.13% | -19.07% | -23.05% |
Yields
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 17, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Earnings Yield | -5.06% | -11.67% | -2.73% | -3.35% | -2.21% | -4.21% |
FCF Yield | -3.23% | -7.01% | -1.87% | -2.94% | -2.01% | -2.42% |
Buyback Yield / Dilution | -4.37% | -8.47% | -3.29% | -5.07% | -43.60% | -2289.13% |
Total Shareholder Return | -4.37% | -8.47% | -3.29% | -5.07% | -43.60% | -2289.13% |